Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Sees Large Growth in Short Interest

Bluejay Diagnostics, Inc. (NASDAQ:BJDX) was the target of a significant growth in short interest in October. As of October 15th, there was short interest totalling 159,900 shares, a growth of 300.8% from the September 30th total of 39,900 shares. Currently, 1.0% of the company’s stock are sold short. Based on an average daily volume of 3,050,000 shares, the days-to-cover ratio is presently 0.1 days.

Bluejay Diagnostics Stock Up 4.0 %

Shares of BJDX traded up $0.00 during mid-day trading on Friday, hitting $0.10. 1,823,870 shares of the company’s stock were exchanged, compared to its average volume of 1,097,385. Bluejay Diagnostics has a twelve month low of $0.08 and a twelve month high of $34.24. The firm has a fifty day moving average of $0.16 and a two-hundred day moving average of $1.87. The stock has a market cap of $34,776.00, a price-to-earnings ratio of 0.00 and a beta of 0.70.

Bluejay Diagnostics (NASDAQ:BJDX) last announced its quarterly earnings data on Wednesday, August 14th. The company reported ($5.12) EPS for the quarter.

Hedge Funds Weigh In On Bluejay Diagnostics

A hedge fund recently bought a new stake in Bluejay Diagnostics stock. CVI Holdings LLC purchased a new position in shares of Bluejay Diagnostics, Inc. (NASDAQ:BJDX) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 66,165 shares of the company’s stock, valued at approximately $46,000. CVI Holdings LLC owned about 19.69% of Bluejay Diagnostics as of its most recent SEC filing. 18.47% of the stock is owned by hedge funds and other institutional investors.

Bluejay Diagnostics Company Profile

Bluejay Diagnostics, Inc, a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components.